✦ LIBER ✦

Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib

✍ Scribed by Cataldo, Vince D.; Gibbons, Don L.; Pérez-Soler, Román; Quintás-Cardama, Alfonso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate end points for survival in the

✍ Xiaoqin Li, Shan Liu, Hangang Gu, Deqiang Wang 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 372 KB

Erlotinib in advanced non-small-cell lun

✍ Zheng-Tao Zhou; Xin-Hua Xu; Qing Wei; Ming-qian Lu; Jie Wang; Cai-Hong Wen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 262 KB

Erlotinib response of EGFR-mutant gefiti

✍ Chang, John Wen-Cheng; Chou, Chun-Liang; Huang, Shiu-Feng; Wang, Hung-Ming; Hsie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Erlotinib, docetaxel, and gefitinib in s

✍ Popat, Sanjay; Barbachano, Yolanda; Ashley, Sue; Norton, Alison; O’Brien, Mary 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Cerebrospinal fluid concentration of gef

✍ Yosuke Togashi, Katsuhiro Masago, Satohiro Masuda… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 301 KB

Erlotinib or gefitinib for the treatment

✍ Mark Murphy; Britta Stordal 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 693 KB